Home › Trial NCT02919735
Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)
- Trial IDNCT02919735
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorLegacy Healthcare SA
- Enrollment40
- Start date2016-10
- ConditionsAlopecia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.